Nivolumab plus ipilimumab with chemotherapy in metastatic NSCLC: minireview and a case study of a patient negative for PD-L1

Alessandro Morabito

Article Type

Case Report

Published

This article is a minireview on the evolutionary course of non-small-cell lung cancer treatment over recent years, and discusses a case involving a patient who tested negative for PD-L1 but experienced a sustained complete response to explore strategies for addressing this specific tumour context.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.